Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata.

Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata.
复制标题

DOI:
10.3389/fimmu.2022.955038
复制
发表时间:
2022
影响因子:
7.3
通讯作者:
--
中科院分区:
医学2区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

斑秃(AA)是一种由T细胞介导的毛囊破坏(HF)引起的自身免疫性疾病。因此,预测有效破坏致病性T细胞反应的方法对AA治疗具有治疗益处。T细胞依赖于T细胞受体(TCR)和γ链(γc)细胞因子信号的双重性来实现其发育、激活和外周稳态。Ifidancitinib是一种有效的选择性下一代JAK1/3抑制剂,预计会破坏γ - c细胞因子信号传导。我们发现,当在饲料中饲喂伊非丹替尼时,伊非丹替尼能强烈地诱导aa影响的C3H/HeJ小鼠的毛发再生。伊非丹昔替尼处理小鼠的皮肤显示aa相关炎症明显减少。与AA发病机制相关的CD44+CD62L- CD8+ T效应细胞/记忆细胞在非非丹替尼治疗小鼠外周淋巴器官中显著减少。我们观察到共抑制受体PD-1在效应/记忆CD8+ T细胞上的高表达,同时在非非替尼处理的小鼠中IFN-γ的产生减少。此外,我们发现γ - c细胞因子调节T细胞衰竭。综上所述,我们的数据表明,使用JAK抑制剂选择性诱导T细胞衰竭可能为这种治疗策略在逆转自身免疫性疾病(如AA)方面的成功提供了机制解释。
Alopecia areata (AA) is an autoimmune disease caused by T cell-mediated destruction of the hair follicle (HF). Therefore, approaches that effectively disrupt pathogenic T cell responses are predicted to have therapeutic benefit for AA treatment. T cells rely on the duality of T cell receptor (TCR) and gamma chain (γc) cytokine signaling for their development, activation, and peripheral homeostasis. Ifidancitinib is a potent and selective next-generation JAK1/3 inhibitor predicted to disrupt γc cytokine signaling. We found that Ifidancitinib robustly induced hair regrowth in AA-affected C3H/HeJ mice when fed with Ifidancitinib in chow diets. Skin taken from Ifidancitinib-treated mice showed significantly decreased AA-associated inflammation. CD44+CD62L- CD8+ T effector/memory cells, which are associated with the pathogenesis of AA, were significantly decreased in the peripheral lymphoid organs in Ifidancitinib-treated mice. We observed high expression of co-inhibitory receptors PD-1 on effector/memory CD8+ T cells, together with decreased IFN-γ production in Ifidancitinib-treated mice. Furthermore, we found that γc cytokines regulated T cell exhaustion. Taken together, our data indicate that selective induction of T cell exhaustion using a JAK inhibitor may offer a mechanistic explanation for the success of this treatment strategy in the reversal of autoimmune diseases such as AA.
DOI: 10.1038/nature14468
发表时间: 2015-07-30
期刊: Nature
影响因子: 64.8
作者:
McKinney EF;Lee JC;Jayne DR;Lyons PA;Smith KG
通讯作者: Smith KG
DOI: 10.1016/j.chembiol.2011.01.012
发表时间: 2011-03-25
影响因子: --
作者:
Haan, Claude;Rolvering, Catherine;Zerwes, Hans-Guenter
通讯作者: Zerwes, Hans-Guenter
DOI: 10.1038/s41586-019-1325-x
发表时间: 2019-07-11
期刊: NATURE
影响因子: 64.8
作者:
Khan, Omar;Giles, Josephine R.;Wherry, E. John
通讯作者: Wherry, E. John
DOI: 10.1016/j.jaad.2016.12.005
发表时间: 2017-04
影响因子: 13.8
作者:
Damsky W;King BA
通讯作者: King BA
DOI: 10.1038/s41586-018-0414-6
发表时间: 2018-08
期刊: Nature
影响因子: 64.8
作者:
La Manno G;Soldatov R;Zeisel A;Braun E;Hochgerner H;Petukhov V;Lidschreiber K;Kastriti ME;Lönnerberg P;Furlan A;Fan J;Borm LE;Liu Z;van Bruggen D;Guo J;He X;Barker R;Sundström E;Castelo-Branco G;Cramer P;Adameyko I;Linnarsson S;Kharchenko PV
通讯作者: Kharchenko PV